National Cancer Institute pediatric preclinical testing program: Model description for in vitro cytotoxicity testing

Abstract

This robust in vitro cytotoxicity testing system for pediatric cancers will enable comparisons to response data for novel agents obtained from xenograft studies and from clinical trials.